1. Home
  2. PDSB vs NSRX Comparison

PDSB vs NSRX Comparison

Compare PDSB & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.25

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.25

Market Cap

25.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PDSB
NSRX
Founded
2005
2019
Country
United States
Israel
Employees
10
7
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6M
25.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
PDSB
NSRX
Price
$1.25
$2.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$9.00
$19.67
AVG Volume (30 Days)
983.1K
49.8K
Earning Date
05-13-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$1.98
52 Week High
$1.90
$9.99

Technical Indicators

Market Signals
Indicator
PDSB
NSRX
Relative Strength Index (RSI) 72.37 35.90
Support Level $1.18 $1.98
Resistance Level $1.40 $5.20
Average True Range (ATR) 0.15 0.20
MACD 0.06 0.10
Stochastic Oscillator 83.21 42.19

Price Performance

Historical Comparison
PDSB
NSRX

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: